This is the authors' abstract. We don't add key points for this paper.
Pure-iodide wide-bandgap (WBG) perovskites (∼1.68 eV) featuring eliminated photoinduced halide segregation are compelling top-cell absorbers for perovskite-silicon tandem solar cells. However, their complex crystallization readily induces heterogeneous composition and structural defects, hindering performance improvements in the resulting devices. Here, we develop a cesium triiodide (CsI3)-mediated strategy to regulate intermediate-phase evolution of pure-iodide WBG perovskites. The CsI3-derived precursor chemistry reconstructs Pb-I coordination networks, suppresses premature organic-dominated intermediate nucleation, and promotes homogeneous phase conversion. The modulated crystallization pathway yields highly crystalline films with improved iodine uniformity and reduced non-radiative recombination losses. Consequently, single-junction solar cells achieve a stabilized power conversion efficiency (PCE) of 22.40%, which retains 95% of its initial efficiency after 1500 h of maximum power point tracking. More importantly, the associated perovskite-silicon solar cells deliver a stabilized PCE of 30.74% along with improved thermal stability, highlighting the great potential of pure-iodide WBG perovskites for efficient and durable tandem photovoltaics.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: